MAGEA3 and neoplasm: When the Wilcoxon signed-rank test was used, we noted that 6 of 18 (33%) CTAs tested, MAGEA3, OIP5, TTK, PLU1, DKKL1, and FBXO39, were significantly (p < 0.05) overexpressed in the tumor compared with normal tissue located ~5 cm away from the primary lesion.